Cardiovascular Features

The aetiology of anaemia in patients with chronic heart failure is multifactorial and therefore difficult to treat. Treatment depends upon the cause and severity of anaemia as determined by investigations. 

Patients with chronic heart failure and anaemia present many diagnostic and management dilemmas. This article discusses the importance of a thorough investigation of the patient.

Subclinical or ‘silent’ atrial fibrillation is the occurrence and detection of subclinical asymptomatic episodes of paroxysmal atrial fibrillation. Research interest has grown in the clinical relevance of atrial fibrillation at an early stage.

Heart failure rates are continuing to rise in the UK, mainly due to improved survival in people with coronary heart disease, particularly after myocardial infarction, and improved use of evidence-based therapies.

Technology to date has been considered to be a driving force in developing many aspects of healthcare provision and point of access care. In atrial fibrillation it can now be used to help make key treatment decisions.

Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published in the European Heart Journal – Cardiovascular Pharmacotherapy.

Atrial fibrillation (AF) affects more than 2.4% of the population. AF-related stroke is a major cause of physical and cognitive disability, and mortality. This article summarises the current recommendations and suggested strategies for AF screening.

The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD) has been published in the European Respiratory Journal.

The use of implantable devices are on the rise and may be used for diagnostic monitoring as well as a treatment option. The requirement for MRI in patients is not an absolute contraindication especially with new devices.

Atrial fibrillation affects more than 2.4% of the population. AF-related stroke is a major cause of physical and cognitive disability, and mortality. This article summarises the current recommendations and suggested strategies for AF screening in the general population.